Nephros Inc
NEPH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001196298
No open-market purchases or sales by Nephros Inc insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Nephros Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 19 | 2 | 17 | 0 |
| Shares | 5.92M | 4.26M | 1.70M | +41.5K (+2.5%) |
| Value | $60.1M | $43.2M | $14.9M | −$1.99M (−11.7%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Nephros Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Total Clarity Wealth Management, Inc. | 653 | $6.00K | 0.00% |
| FMR LLC | 91 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Nephros Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 350 | $3.00K |
| Royal Bank of Canada | 7 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held Nephros Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Wexford Capital LP | 3,631,197 | $36.9M |
| Cowen Prime Services LLC | 626,450 | $6.36M |